Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Pharnext has raised €16M across 3 funding rounds from 2 investors, most recently a round in Feb 2012. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€15,720,000
Funding rounds
3
Investors
2
distinct backers
Active since
2010-06
latest 2012-02
Funding by year
EUR raised per yearPharnext — funding by year — interactive chart.
Data table
| Pharnext — funding by year | |
|---|---|
| 2010 | €5.2M |
| 2011 | €2.5M |
| 2012 | €8.0M |
Signals
High confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-02-01 | Other | €8.0M | Truffle Capital | View deal → |
| 2011-09-01 | Other | €2.5M | Truffle Capital | View deal → |
| 2010-06-01 | Other | €5.2M | Aurinvest | View deal → |
Investors
2Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData